Literature DB >> 26538798

Type 1 Diabetes Patients Using Continuous Subcutaneous Insulin Infusion Therapy: Feeling Burdened Correlated with Factors.

Ikuko Nishio1, Masami Chujo1.   

Abstract

BACKGROUND: The purpose of this study was to investigate factors related to feelings of being burdened in type 1 diabetes patients using continuous subcutaneous insulin infusion (CSII) therapy.
METHODS: Participants were 106 subscribers to the Diabetes Network's e-mail newsletter. An online survey was used. Eligible participants were aged at least 20 years, had type 1 diabetes, and were using CSII. Survey questions concerned whether participants found CSII burdensome, and seven potential reasons for feelings of burden. Analysis calculated correlations among participants' demographic and treatment-related factors, and among participants' reasons for feeling CSII to be burdensome.
RESULTS: Regarding demographic and treatment-related factors, gender was found to be weakly negatively correlated with the following variables: employment status, and whether participants had discussed their concerns with a doctor. Employment status was found to be weakly correlated with diabetes duration; employment status and diabetes duration were found to be weakly correlated with age. Regarding reasons for finding CSII therapy burdensome, "It takes too much time" was found to be strongly positively correlated with "It interferes with work responsibilities"; 16 weak positive correlations were also found.
CONCLUSION: To explain our results, we suggest that medical expenses, glycemic control, scheduling outpatient visits around home and work responsibilities, and interacting with medical staff may have caused participants to find CSII therapy burdensome. Most participants had never discussed their treatment concerns with a doctor. This suggests that nurses may be able to mitigate feeling burdened in participants using CSII therapy.

Entities:  

Keywords:  continuous subcutaneous insulin infusion; feeling burdened; related factors; type 1 diabete

Year:  2015        PMID: 26538798      PMCID: PMC4626358     

Source DB:  PubMed          Journal:  Yonago Acta Med        ISSN: 0513-5710            Impact factor:   1.641


  11 in total

Review 1.  Insulin-pump therapy for type 1 diabetes mellitus.

Authors:  John C Pickup
Journal:  N Engl J Med       Date:  2012-04-26       Impact factor: 91.245

2.  Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII.

Authors:  Irl B Hirsch; Bruce W Bode; Satish Garg; Wendy S Lane; Allen Sussman; Peter Hu; Olga M Santiago; Jerzy W Kolaczynski
Journal:  Diabetes Care       Date:  2005-03       Impact factor: 19.112

3.  Insulin pump therapy: a meta-analysis.

Authors:  Jill Weissberg-Benchell; Jeanne Antisdel-Lomaglio; Roopa Seshadri
Journal:  Diabetes Care       Date:  2003-04       Impact factor: 19.112

4.  Young women with type 1 diabetes' management of turning points and transitions.

Authors:  Bodil Rasmussen; Beverly O'Connell; Patricia Dunning; Helen Cox
Journal:  Qual Health Res       Date:  2007-03

5.  Perceptions of psychosocial factors and the insulin pump.

Authors:  Marilyn D Ritholz; Arlene Smaldone; Jarim Lee; Astrid Castillo; Howard Wolpert; Katie Weinger
Journal:  Diabetes Care       Date:  2007-03       Impact factor: 19.112

Review 6.  Diabetes technology and the human factor.

Authors:  A Liberman; B Buckingham; M Phillip
Journal:  Int J Clin Pract Suppl       Date:  2011-02

7.  Insulin pump use in adults with type 1 diabetes--practical issues.

Authors:  Greeshma Shetty; Howard Wolpert
Journal:  Diabetes Technol Ther       Date:  2010-06       Impact factor: 6.118

Review 8.  Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis.

Authors:  K Jeitler; K Horvath; A Berghold; T W Gratzer; K Neeser; T R Pieber; A Siebenhofer
Journal:  Diabetologia       Date:  2008-03-20       Impact factor: 10.122

9.  The health care costs of diabetic peripheral neuropathy in the US.

Authors:  Adam Gordois; Paul Scuffham; Arran Shearer; Alan Oglesby; Janet Ash Tobian
Journal:  Diabetes Care       Date:  2003-06       Impact factor: 19.112

10.  Opinions and Satisfaction Regarding Continuous Subcutaneous Insulin Infusion Therapy in Adult Patients with Type 1 Diabetes.

Authors:  Ikuko Nishio; Masami Chujo; Tsuyoshi Ohkura; Hideyuki Kataoka
Journal:  Yonago Acta Med       Date:  2015-10-14       Impact factor: 1.641

View more
  2 in total

1.  Structure of Resilience among Japanese Adult Patients with Type 1 Diabetes: A Qualitative Study.

Authors:  Ikuko Nishio; Masami Chujo
Journal:  Yonago Acta Med       Date:  2017-03-09       Impact factor: 1.641

2.  A Qualitative Study of Confusing Experiences among Japanese Adult Patients with Type 1 Diabetes.

Authors:  Ikuko Nishio; Masami Chujo; Hideyuki Kataoka
Journal:  Yonago Acta Med       Date:  2016-04-01       Impact factor: 1.641

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.